tiprankstipranks
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market
FDMT
4D Molecular Therapeutics
RESEARCH TOOLSreports
Want to see FDMT full AI Analyst Report?

4D Molecular Therapeutics (FDMT) Income Statement

527 Followers

4D Molecular Therapeutics Income Statement

Last quarter (Q2 2026), 4D Molecular Therapeutics's total revenue was $3.78M, an increase of 25106.67% from the same quarter last year. In Q2, 4D Molecular Therapeutics's net income was $-72.94M. See 4D Molecular Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 85.21M$ 37.00K$ 20.72M$ 3.13M$ 18.04M
Gross Profit
$ 77.58M$ -141.26M$ -76.37M$ -77.12M$ -43.32M
Operating Expenses
$ 237.13M$ 46.58M$ 36.49M$ 32.91M$ 28.01M
Depreciation and Amortization
$ 7.63M$ 6.71M$ 4.20M$ 2.40M$ 1.52M
EBITDA
$ -132.48M$ -154.16M$ -96.63M$ -105.09M$ -69.79M
Operating Income
$ -159.55M$ -187.84M$ -112.87M$ -110.03M$ -71.33M
Other Income/Expenses
$ 19.44M$ 26.97M$ 12.03M$ 2.54M$ 16.00K
Pretax Income
$ -140.11M$ -160.87M$ -100.84M$ -107.49M$ -71.32M
Net Income
$ -140.11M$ -160.87M$ -100.84M$ -107.49M$ -71.32M
Per Share Metrics
Basic EPS
$ -2.42$ -2.98$ -2.58$ -3.12$ -2.46
Diluted EPS
$ -2.42$ -2.98$ -2.58$ -3.12$ -2.46
Weighted Average Shares Outstanding
 57.93M 53.94M 39.13M 32.35M 27.73M
Weighted Average Shares Outstanding (Diluted)
 57.93M 53.94M 39.13M 32.35M 27.73M
Currency in USD

4D Molecular Therapeutics Earnings and Revenue History